Vertigo, a sensation of feeling off balance, is often associated with a range of vestibular disorders. It is crucial for healthcare professionals to understand the complexities of this symptom to provide effective diagnosis and treatment.
Vertigo is characterized by a perceived sense of rotation or movement, either of the self or the environment. It is often linked to inner ear problems, such as Benign Paroxysmal Positional Vertigo (BPPV), Meniere's disease, or Vestibular neuritis. It can also be a symptom of central nervous system disorders like stroke or migraines.
Diagnosing vertigo involves a comprehensive clinical approach. It begins with a detailed patient history, focusing on the nature, duration, and triggers of the vertigo episodes. Physical examination, including bedside tests like the Dix-Hallpike maneuver for BPPV, is essential. Further, neuroimaging or vestibular function tests may be required based on the initial findings.
Treatment of vertigo is primarily directed towards the underlying cause. For peripheral causes like BPPV, physical maneuvers are often effective. Meniere's disease may require dietary modifications and diuretics. Central causes necessitate a more specialized approach, often involving neurologists. Medications like vestibular suppressants can be used for symptomatic relief, but their long-term use is not recommended due to potential side effects and dependency.
Vestibular rehabilitation therapy (VRT) is an exercise-based program designed to promote central nervous system compensation for inner ear deficits. It can be a useful adjunct in managing chronic, non-resolving vertigo, improving the patient's balance and reducing the frequency of vertigo episodes.
Vertigo is a challenging symptom that demands a comprehensive and multidisciplinary approach. Accurate diagnosis and targeted treatment, combined with patient education and rehabilitation strategies, can significantly improve patient outcomes and quality of life.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation